Markus Lundgren
31 – 40 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
- Contribution to journal › Article
-
Mark
Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children
- Contribution to journal › Article
-
Mark
The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study
- Contribution to journal › Article
-
Mark
Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study
- Contribution to journal › Article
- 2021
-
Mark
DPVis : Visual Analytics with Hidden Markov Models for Disease Progression Pathways
- Contribution to journal › Article
-
Mark
Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes
- Contribution to journal › Article
-
Mark
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts
- Contribution to journal › Article
-
Mark
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study : TEFA
- Contribution to journal › Article
-
Mark
First-appearing islet autoantibodies for type 1 diabetes in young children : maternal life events during pregnancy and the child's genetic risk
- Contribution to journal › Article
-
Mark
Imputing Longitudinal Growth Data in International Pediatric Studies : Does CDC Reference Suffice?
- Contribution to journal › Article
